Original Source(s)
Related Content
Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial
An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.
by Teraya Smith
July 23, 2026
-
3 min
Could Pregnancy Complications Predict CVD Risk?
Investigators found that adding pregnancy-related and female-specific factors modestly improved postpartum cardiovascular risk prediction compared with traditional risk factors alone.
August 5, 2026
-
4 min
Weekly HIV Therapy Meets Primary Endpoint
Patients who switched from daily antiretroviral therapy maintained virologic suppression in two phase 3 trials.
July 23, 2026
-
3 min
